Ledger.Open graph →
SEC Form D · filed May 2, 2016

Gila Therapeutics, Inc

Offering
$3.2M
Sold
$2.6M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Minneapolis, MN
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (20)

Christopher J. Desouza · Minneapolis, MNDirectorThomas J. Vasicek · Minneapolis, MNExec · DirectorSergei J. Zolutukhin · Minneapolis, MNPromoterRichard J. Horan · Minneapolis, MNDirectorJon J. Freeman · Minneapolis, MNExecAndres J. Acosta · Minneapolis, MNPromoterMichael R. Cardenas · Minneapolis, MNPromoterDavid Mc Geough · Killiney, Dublin, IrelandExecRichard J. Horan · Minneapolis, MNDirectorBenneth C. Cachila · Austin, TXDirectorLarry Perdido · Austin, TXPromoterRaul C. Romero · Austin, TXPromoterRobert K. Lewis · Austin, TXExec · DirectorGordon G. Repp · Chicago, ILDirectorDemetri G. Rackos · Chicago, ILExecJoseph K. Munoz · Chicago, ILPromoterTy G. Spearing · Chicago, ILDirectorRobert K. Hagan · Chicago, ILExec · DirectorRobert B. Crumpton, Iii · Birmingham, ALPromoterMichael R. Cardenas · Minneapolis, MNPromoter

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗